[go: up one dir, main page]

WO2004067018A8 - Bioavailability enhancing activity of carum carvi extracts and fractions thereof - Google Patents

Bioavailability enhancing activity of carum carvi extracts and fractions thereof

Info

Publication number
WO2004067018A8
WO2004067018A8 PCT/IB2003/000293 IB0300293W WO2004067018A8 WO 2004067018 A8 WO2004067018 A8 WO 2004067018A8 IB 0300293 W IB0300293 W IB 0300293W WO 2004067018 A8 WO2004067018 A8 WO 2004067018A8
Authority
WO
WIPO (PCT)
Prior art keywords
extracts
fractions
enhancing activity
carum carvi
bioavailability enhancing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2003/000293
Other languages
French (fr)
Other versions
WO2004067018A1 (en
Inventor
Ghulam Nabi Qazi
Kasturi Lal Bedi
Rakesh Kamal Johri
Manoj Kumar Tikoo
Ashok Kumar Tikoo
Subhash Chander Sharma
Tasduq Abdullah
Om Prakash Suri
Bishan Datt Gupta
Krishan Avtar Suri
Naresh Kumar Satti
Ravi Kant Khajuria
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council of Scientific and Industrial Research CSIR
Original Assignee
Council of Scientific and Industrial Research CSIR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council of Scientific and Industrial Research CSIR filed Critical Council of Scientific and Industrial Research CSIR
Priority to EP03700970A priority Critical patent/EP1587521A1/en
Priority to JP2004567372A priority patent/JP2006514962A/en
Priority to PCT/IB2003/000293 priority patent/WO2004067018A1/en
Priority to CNA038259028A priority patent/CN1738632A/en
Priority to AU2003202112A priority patent/AU2003202112A1/en
Publication of WO2004067018A1 publication Critical patent/WO2004067018A1/en
Anticipated expiration legal-status Critical
Publication of WO2004067018A8 publication Critical patent/WO2004067018A8/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/19—Acanthaceae (Acanthus family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to the use of extracts of Carum carvi as bioenhancers, either alone or in combination with piperine or Zinzeber officinale extract to improve the bioavailability of a wide variety of drugs.
PCT/IB2003/000293 2003-01-30 2003-01-30 Bioavailability enhancing activity of carum carvi extracts and fractions thereof Ceased WO2004067018A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP03700970A EP1587521A1 (en) 2003-01-30 2003-01-30 Bioavailability enhancing activity of carum carvi extracts and fractions thereof
JP2004567372A JP2006514962A (en) 2003-01-30 2003-01-30 Bioavailability to enhance the activity of caraway extract and its fractions
PCT/IB2003/000293 WO2004067018A1 (en) 2003-01-30 2003-01-30 Bioavailability enhancing activity of carum carvi extracts and fractions thereof
CNA038259028A CN1738632A (en) 2003-01-30 2003-01-30 Bioavailability enhancing activity of caraway seed extract and its fractions
AU2003202112A AU2003202112A1 (en) 2003-01-30 2003-01-30 Bioavailability enhancing activity of carum carvi extracts and fractions thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2003/000293 WO2004067018A1 (en) 2003-01-30 2003-01-30 Bioavailability enhancing activity of carum carvi extracts and fractions thereof

Publications (2)

Publication Number Publication Date
WO2004067018A1 WO2004067018A1 (en) 2004-08-12
WO2004067018A8 true WO2004067018A8 (en) 2006-02-23

Family

ID=32800536

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2003/000293 Ceased WO2004067018A1 (en) 2003-01-30 2003-01-30 Bioavailability enhancing activity of carum carvi extracts and fractions thereof

Country Status (5)

Country Link
EP (1) EP1587521A1 (en)
JP (1) JP2006514962A (en)
CN (1) CN1738632A (en)
AU (1) AU2003202112A1 (en)
WO (1) WO2004067018A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2067475A4 (en) 2006-09-26 2010-12-15 Astellas Pharma Inc Tacrolimus sustained-release preparation
WO2008084698A1 (en) 2006-12-28 2008-07-17 Astellas Pharma Inc. Tacrolimus sustained release pharmaceutical composition
CN102133385A (en) * 2011-03-02 2011-07-27 青岛大学 Ginger and white pepper composition, preparation method thereof and application thereof to preparation of medicaments for attenuation and synergia in cancer radiochemotherapy
CN102757865B (en) * 2011-04-25 2013-06-05 湖北中烟工业有限责任公司 Carum carvi and dried ginger composite extract and purpose thereof as tobacco product additive
FR2979826B1 (en) * 2011-09-08 2013-12-27 Univ Bordeaux Segalen ANTI-INFLAMMATORY COMPOSITION
US20170232020A1 (en) * 2016-02-12 2017-08-17 Cipla Limited Pharmaceutical compositions
IT201600075072A1 (en) * 2016-07-18 2018-01-18 Nathura S P A Pharmaceutical or dietary supplement composition for the treatment of intestinal constipation
CN108205032A (en) * 2017-12-29 2018-06-26 佛山市南海东方澳龙制药有限公司 The detection method of ketoconazole ingredient liquid content in a kind of compound ketoconazole ointment
US20210299203A1 (en) * 2020-03-26 2021-09-30 Johnson & Johnson Consumer Inc. Compositions comprising carum carvi and rosmarinus officinalis extracts and methods of using same

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3511862A1 (en) * 1985-04-01 1986-10-09 Klinge Co Chem Pharm Fab Pharmaceutical composition
CA2076980C (en) * 1990-03-02 1997-03-18 Isaac G. Eliaz Method and product for promoting hair growth and treating skin conditions
ES2153362T3 (en) * 1991-08-26 2001-03-01 Abbott Lab COMPOSITIONS AND PROCEDURES OF SUBLINGUAL OR BUCAL ADMINISTRATION OF THERAPEUTIC AGENTS.
JP2946452B2 (en) * 1994-11-04 1999-09-06 カディラ ラボラトリーズ リミテッド Composition containing piperine
US5744161A (en) * 1995-02-24 1998-04-28 Sabinsa Corporation Use of piperine as a bioavailability enhancer
US5916566A (en) * 1995-06-07 1999-06-29 Avmax, Inc. Use of benzoin gum to inhibit P-glycoprotein-mediated resistance of pharmaceutical compounds
CH688787A5 (en) * 1995-09-05 1998-03-31 Dieter Linsig Synergistic mixture of essential oils or essences
IN186315B (en) * 1996-12-12 2001-08-04 Panacea Biotec Ltd
DE10022801A1 (en) * 2000-05-10 2001-11-15 Ernestina C Loeckinger Well tolerated natural medicament for treating urological, gynecological or intestinal diseases, comprising black caraway oil, tea tree oil and grapefruit seed extract.
DE10196213T1 (en) * 2000-05-19 2003-04-30 Sabinsa Corp Process of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and analogues and derivatives thereof
JP2002138045A (en) * 2000-10-30 2002-05-14 Ichimaru Pharcos Co Ltd Inhibitor for inhibiting differentiation induction of pre- adipocyte
JP2003095915A (en) * 2001-09-25 2003-04-03 Shiseido Co Ltd Skin care composition

Also Published As

Publication number Publication date
JP2006514962A (en) 2006-05-18
EP1587521A1 (en) 2005-10-26
CN1738632A (en) 2006-02-22
WO2004067018A1 (en) 2004-08-12
AU2003202112A8 (en) 2004-08-23
AU2003202112A1 (en) 2004-08-23

Similar Documents

Publication Publication Date Title
IL184288A0 (en) 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same
GB2366565B (en) Extract potent in anti-inflammation, anti-platelet aggregation and anti-fungal activity from Zingiber Officinale and pharmaceuticals containing said extract
CA121365S (en) Commuter mug
HUP0400375A3 (en) Composition containing fat oil and onion extract, the production and use thereof
WO2006091529A3 (en) A solid pharmaceutical dosage formulation
EP1784163A4 (en) Nano-emulsion, the use thereof, and preparation method thereof
IL180762A0 (en) Insulin-oligomer conjugates, formulations and uses thereof
IL169647A (en) Hiv replication inhibiting pyrimidines, their use in the preparation of pharmaceutical compositions and pharmaceutical compositions comprising them
CA102224S (en) Dispensing cap
ZA200700680B (en) Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
CA105215S (en) Packaging with cosmetic composition
DE602004025108D1 (en) MARBURNED BOUILLON, SUD, SOUPS, SAUCES OR CREAMS AND ITS MANUFACTURING METHOD
WO2004067018A8 (en) Bioavailability enhancing activity of carum carvi extracts and fractions thereof
CA102225S (en) Dispensing cap
WO2003068157A3 (en) Kinase inhibitors and methods of use thereof
WO2007019373A3 (en) Novel formulations comprising fenofibrate and a statin, and related methods of treatment
IL169366A0 (en) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
AP2006003530A0 (en) Immunogenic HIV compositions and related methods.
IL176513A0 (en) Diarylmethyl piperazine derivatives, preparations thereof and used thereof
GB0317877D0 (en) Pharmaceutical combinations and formulations with improved stability
ZA200800966B (en) Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics
IL169360A0 (en) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
AP2006003567A0 (en) Herbal extracts of salicornia species, use thereofagainst tuberculosis.
WO2007017646A3 (en) Anti-malarial composition comprising artesunate and lumefantrine
IL180544A0 (en) Diarylmethyl piperazine derivatives, preparations thereof and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2003700970

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2004567372

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 20038259028

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 2003700970

Country of ref document: EP

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 33/2004 UNDER (72) REPLACE "QAFI, GHULAM, NABI" BY "QAZI, GHULAM, NABI"